Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders-Reference-Cited by-同舟云学术

Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders

Published:2010-03 Issue:3 Volume:17 Page:185-191
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:

Author:

Imai Y.,Tamura S.,Tanaka H.,Hiramatsu N.,Kiso S.,Doi Y.,Inada M.,Nagase T.,Kitada T.,Imanaka K.,Fukuda K.,Takehara T.,Kasahara A.,Hayashi N.

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2009.01163.x/fullpdf

Reference32 articles.

1. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future;Yoshizawa;Oncology,2002

2. Liver cancer and its prevention;Tsukuma;Asian Pac J Cancer Prev,2005

3. Characteristics of Japanese patients with liver cancer - epidemiological study based on a comparison between male and female patients;Tanaka;Hepatol Res,2002

4. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality;Tanaka;Gastroenterology,2006

5. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003;Tanaka;Ann Intern Med,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C-Induced Hepatocellular Carcinoma in the Middle East;Liver Cancer in the Middle East;2021

2. Treatment of chronic hepatitis C regiments containing with recombinant interferon in patients with sustained virological response predicts risk of hepatocellular carcinoma;Medicine;2020-10-02

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves

;Journal of Hepatocellular Carcinoma;2019-11

4. Real-world clinical outcomes among individuals with chronic HCV infection in China: CCgenos study;Antiviral Therapy;2019

5. The presence of multiple NS 5A RAS s is associated with the outcome of sofosbuvir and ledipasvir therapy in NS 5A inhibitor‐naïve patients with chronic HCV genotype 1b infection in a real‐world cohort;Journal of Viral Hepatitis;2018-01-17